Our studies focus on bacteria of the human microbiome including Campylobacter and Helicobacter species that live in the mucus layer overlying the mucosal epithelium of mammals, including humans. Specifically, we explore the biology of colonization and the nature of the interactions that lead to (or protect from) disease. For the normal microbiome, we study how early life perturbations affect host developmental phenotypes. Our on-going work focuses on the metabolic syndrome, and specifically on obesity and type 2 diabetes, as well as inflammatory disorders such as type 1 diabetes, asthma, psoriasis, and skin infections.
Muriel G. and George W. Singer Professor of Translational Medicine, Department of Medicine
Professor, Department of Microbiology
Director Human Microbiome Program
MD from New York University
Nephrology, dialysis, transplantation. 2017 Mar 31; ?-?
International journal of systematic & evolutionary microbiology. 2017 Jan 16; ?-?
Cell host & microbe. 2016 Nov 09; 20(5):558-560
Helicobacter. 2016 Oct 27; 22(2):?-?
Clinical infectious diseases. 2016 Oct 01; 63(7):937-943
Does the Diversity of the Microbiome Reflect Possible Colonic Polyps in a Multi-ethnic Population? [Meeting Abstract]
American journal of gastroenterology. 2016 Oct; 111:S62-S63
Journal of the American Academy of Dermatology. 2016 Sep; 75(3):481-493.e8